Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [<sup>153</sup>Sm]Sm-DOTA-TATE.

导出 OA

翻译打印收藏纠错

第一作者： Koen,Vermeulen

第一单位： NURA Research Group, Belgian Nuclear Research Center (SCK CEN), 2400 Mol, Belgium.

作者： Koen,Vermeulen ^[1] ; Michiel,Van de Voorde ^[1] ; Charlotte,Segers ^[1] ; Amelie,Coolkens ^[1] ; Sunay,Rodriguez Pérez ^[1] ; Noami,Daems ^[1] ; Charlotte,Duchemin ^[2] ; Melissa,Crabbé ^[1] ; Tomas,Opsomer ^[1] ; Clarita,Saldarriaga Vargas ^[3] ; Reinhard,Heinke ^[2] ; Laura,Lambert ^[4] ; Cyril,Bernerd ^[2] ; Andrew R,Burgoyne ^[1] ; Thomas Elias,Cocolios ^[5] ; Thierry,Stora ^[4] ; Maarten,Ooms ^[1]

作者单位： NURA Research Group, Belgian Nuclear Research Center (SCK CEN), 2400 Mol, Belgium. ^[1] Institute for Nuclear and Radiation Physics, KU Leuven, 3000 Leuven, Belgium.;MEDICIS, Conseil Européen pour la Recherche Nucléaire (CERN), 1211 Geneva, Switzerland. ^[2] Research in Dosimetric Applications, Belgian Nuclear Research Center (SCK CEN), 2400 Mol, Belgium. ^[3] MEDICIS, Conseil Européen pour la Recherche Nucléaire (CERN), 1211 Geneva, Switzerland. ^[4] Institute for Nuclear and Radiation Physics, KU Leuven, 3000 Leuven, Belgium. ^[5]

关键词 DOTA-TATE SSTR2 samarium-153 targeted radionuclide therapy

DOI 10.3390/pharmaceutics14122566

PMID 36559060

发布时间 2023-03-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交